Vulvar Cancer Operative Morbidity & Mortality

Key points
- The most frequently encountered complication is wound breakdown, which occurs in well over 50% of patients undergoing radical vulvectomy and bilateral inguinal dissection.
- After the immediate postoperative period, patients should be examined every 3 months for 2 years and every 6 months thereafter to detect recurrent disease or a second primary cancer.
- This complication is related to the amount of skin removed during the procedure, particularly at the groin areas.
- Separate groin incisions and careful handling of skin flaps have reduced the incidence of wound breakdown.
Operative Morbidity & Mortality
The most frequently encountered complication is wound breakdown, which occurs in well over 50% of patients undergoing radical vulvectomy and bilateral inguinal dissection. This complication is related to the amount of skin removed during the procedure, particularly at the groin areas.
Separate groin incisions and careful handling of skin flaps have reduced the incidence of wound breakdown. Vigorous wound care with debridement almost always results in adequate healing.
Lymphedema occurs in approximately 65% of patients who have had radical vulvectomy. Hemorrhage, lymphocyst formation, thromboembolic disease, urinary tract infections, and sexual dysfunction are other commonly associated morbidities.
Follow-Up
After the immediate postoperative period, patients should be examined every 3 months for 2 years and every 6 months thereafter to detect recurrent disease or a second primary cancer. Nearly 80% of recurrent vulvar cancer occurs in the first 2 years. Treatment modalities depend on the location of recurrence. Malignant melanomas and sarcomas may recur locally or metastasize to the liver or lungs.
{embed="cr/stat-menu-vulva"}
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsResponse to preoperative therapy may predict survival in pancreatic cancer patients
Cancer of the pancreas––a glandular organ that lies behind the stomach and secretes vital enzymes and hormones––seldom is detected in early stages, making treatment difficult and survival statistics particularly grim.…
1 June 2010
NewsPreoperative/neoadjuvant therapy in pancreatic cancer
In research published this week in PLoS Medicine, Jörg Kleeff from Technische Universität München, and colleagues suggest that patients with apparently locally non-resectable tumors should be included in neoadjuvant…
22 April 2010
NewsCancer Mortality Rates Experience Steady Decline
The number of cancer deaths has declined steadily in the last three decades. Although younger people have experienced the steepest declines, all age groups have shown some improvement, according to a recent report in…





